a a polypharma limited

3.5

a a polypharma limited Company Information

Share A A POLYPHARMA LIMITED
Live 
EstablishedSmallLow

Company Number

08596634

Website

-

Registered Address

the gatehouse, 453 cranbrook road, ilford, essex, IG2 6EW

Industry

Dispensing chemist in specialised stores

 

Telephone

-

Next Accounts Due

December 2024

Group Structure

View All

Directors

Suzanne Oberlander10 Years

Ariel Oberlander10 Years

Shareholders

ariel oberlander 52%

suzanne oberlander 48%

a a polypharma limited Estimated Valuation

£280.3k

Pomanda estimates the enterprise value of A A POLYPHARMA LIMITED at £280.3k based on a Turnover of £1.4m and 0.19x industry multiple (adjusted for size and gross margin).

a a polypharma limited Estimated Valuation

£137.6k

Pomanda estimates the enterprise value of A A POLYPHARMA LIMITED at £137.6k based on an EBITDA of £71.9k and a 1.91x industry multiple (adjusted for size and gross margin).

a a polypharma limited Estimated Valuation

£0

Pomanda estimates the enterprise value of A A POLYPHARMA LIMITED at £0 based on Net Assets of £-254.8k and 2.03x industry multiple (adjusted for liquidity).

Valuation Calculator
This valuation is estimated based on financial data from March 2023 

A A Polypharma Limited AI Business Plan

In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.

View Sample

A A Polypharma Limited Overview

A A Polypharma Limited is a live company located in ilford, IG2 6EW with a Companies House number of 08596634. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in July 2013, it's largest shareholder is ariel oberlander with a 52% stake. A A Polypharma Limited is a established, small sized company, Pomanda has estimated its turnover at £1.4m with low growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

A A Polypharma Limited Health Check

Pomanda's financial health check has awarded A A Polypharma Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3.5out of 5
positive_score

3 Strong

positive_score

2 Regular

positive_score

5 Weak

size

Size

annual sales of £1.4m, make it smaller than the average company (£12.1m)

£1.4m - A A Polypharma Limited

£12.1m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 4%, show it is growing at a slower rate (5.2%)

4% - A A Polypharma Limited

5.2% - Industry AVG

production

Production

with a gross margin of 26.3%, this company has a comparable cost of product (31.4%)

26.3% - A A Polypharma Limited

31.4% - Industry AVG

profitability

Profitability

an operating margin of 5% make it more profitable than the average company (3.5%)

5% - A A Polypharma Limited

3.5% - Industry AVG

employees

Employees

with 8 employees, this is below the industry average (84)

8 - A A Polypharma Limited

84 - Industry AVG

paystructure

Pay Structure

on an average salary of £22k, the company has an equivalent pay structure (£22k)

£22k - A A Polypharma Limited

£22k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £181k, this is more efficient (£139.2k)

£181k - A A Polypharma Limited

£139.2k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 46 days, this is later than average (30 days)

46 days - A A Polypharma Limited

30 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 217 days, this is slower than average (67 days)

217 days - A A Polypharma Limited

67 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - A A Polypharma Limited

- - Industry AVG

cashbalance

Cash Balance

There is insufficient data available for this Key Performance Indicator!

- - A A Polypharma Limited

- - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 162.5%, this is a higher level of debt than the average (61%)

162.5% - A A Polypharma Limited

61% - Industry AVG

a a polypharma limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for a a polypharma limited. Get real-time insights into a a polypharma limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

A A Polypharma Limited Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for a a polypharma limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

a a polypharma limited Ownership

A A POLYPHARMA LIMITED group structure

A A Polypharma Limited has no subsidiary companies.

Ultimate parent company

A A POLYPHARMA LIMITED

08596634

A A POLYPHARMA LIMITED Shareholders

ariel oberlander 52%
suzanne oberlander 48%

a a polypharma limited directors

A A Polypharma Limited currently has 2 directors. The longest serving directors include Ms Suzanne Oberlander (Jul 2013) and Mr Ariel Oberlander (Jul 2013).

officercountryagestartendrole
Ms Suzanne OberlanderEngland62 years Jul 2013- Director
Mr Ariel Oberlander59 years Jul 2013- Director

A A POLYPHARMA LIMITED financials

EXPORTms excel logo

A A Polypharma Limited's latest turnover from March 2023 is estimated at £1.4 million and the company has net assets of -£254.8 thousand. According to their latest financial statements, A A Polypharma Limited has 8 employees and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
Turnover1,447,9551,008,2241,315,0951,297,9501,277,2051,797,6701,883,8281,616,9351,559,8701,122,654
Other Income Or Grants0000000000
Cost Of Sales1,067,428731,153990,575978,285958,3341,320,5471,367,3541,179,7371,145,652809,936
Gross Profit380,527277,071324,521319,665318,871477,123516,474437,198414,218312,718
Admin Expenses308,621268,027241,583-98,142460,665578,460636,845627,328495,988403,667
Operating Profit71,9069,04482,938417,807-141,794-101,337-120,371-190,130-81,770-90,949
Interest Payable0000000000
Interest Receivable0000969517137969
Pre-Tax Profit71,9069,04482,938417,807-141,698-101,242-120,354-190,117-81,691-90,880
Tax-13,662-1,718-15,758-79,383000000
Profit After Tax58,2447,32667,180338,424-141,698-101,242-120,354-190,117-81,691-90,880
Dividends Paid0000000000
Retained Profit58,2447,32667,180338,424-141,698-101,242-120,354-190,117-81,691-90,880
Employee Costs175,653164,449155,022189,279129,474365,025354,116191,324172,634137,829
Number Of Employees888107202011108
EBITDA*71,9069,04482,938417,807-141,7942,815-15,070-78,67227,36120,342

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
Tangible Assets223,323254,705286,088317,876353,19516,46722,97610,63319,44125,922
Intangible Assets000001,449,6301,547,273855,610958,260923,850
Investments & Other0000000000
Debtors (Due After 1 year)0000000000
Total Fixed Assets223,323254,705286,088317,876353,1951,466,0971,570,249866,243977,701949,772
Stock & work in progress0000085,200120,500145,500135,35071,825
Trade Debtors184,238131,871198,552140,838159,815227,543270,397204,103205,576160,983
Group Debtors0000000000
Misc Debtors0000000000
Cash0000025,66012,4631,2084,02327,454
misc current assets0000000000
total current assets184,238131,871198,552140,838159,815338,403403,360350,811344,949260,262
total assets407,561386,576484,640458,714513,0101,804,5001,973,6091,217,0541,322,6501,210,034
Bank overdraft0000000000
Bank loan0000000000
Trade Creditors 636,231468,456755,018846,272847,5591,199,0431,134,779935,066787,699562,714
Group/Directors Accounts0000000000
other short term finances0000000000
hp & lease commitments0000000000
other current liabilities0000000000
total current liabilities636,231468,456755,018846,272847,5591,199,0431,134,779935,066787,699562,714
loans0000000000
hp & lease commitments0000000000
Accruals and Deferred Income0000000000
other liabilities26,138231,17250,0000391,4331,189,5411,321,672644,476707,322738,000
provisions0000000000
total long term liabilities26,138231,17250,0000391,4331,189,5411,321,672644,476707,322738,000
total liabilities662,369699,628805,018846,2721,238,9922,388,5842,456,4511,579,5421,495,0211,300,714
net assets-254,808-313,052-320,378-387,558-725,982-584,084-482,842-362,488-172,371-90,680
total shareholders funds-254,808-313,052-320,378-387,558-725,982-584,084-482,842-362,488-172,371-90,680
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
Operating Activities
Operating Profit71,9069,04482,938417,807-141,794-101,337-120,371-190,130-81,770-90,949
Depreciation000006,5097,6588,8086,4818,641
Amortisation0000097,64397,643102,650102,650102,650
Tax-13,662-1,718-15,758-79,383000000
Stock0000-85,200-35,300-25,00010,15063,52571,825
Debtors52,367-66,68157,714-18,977-67,728-42,85466,294-1,47344,593160,983
Creditors167,775-286,562-91,254-1,287-351,48464,264199,713147,367224,985562,714
Accruals and Deferred Income0000000000
Deferred Taxes & Provisions0000000000
Cash flow from operations173,652-212,555-81,788356,114-340,350145,233143,34960,018144,228350,248
Investing Activities
capital expenditure31,38231,38331,78835,3191,112,9020-809,3070-137,060-1,061,063
Change in Investments0000000000
cash flow from investments31,38231,38331,78835,3191,112,9020-809,3070-137,060-1,061,063
Financing Activities
Bank loans0000000000
Group/Directors Accounts0000000000
Other Short Term Loans 0000000000
Long term loans0000000000
Hire Purchase and Lease Commitments0000000000
other long term liabilities-205,034181,17250,000-391,433-798,108-132,131677,196-62,846-30,678738,000
share issue0000-2000000200
interest0000969517137969
cash flow from financing-205,034181,17250,000-391,433-798,212-132,036677,213-62,833-30,599738,269
cash and cash equivalents
cash0000-25,66013,19711,255-2,815-23,43127,454
overdraft0000000000
change in cash0000-25,66013,19711,255-2,815-23,43127,454

P&L

March 2023

turnover

1.4m

+44%

operating profit

71.9k

0%

gross margin

26.3%

-4.37%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2023

net assets

-254.8k

-0.19%

total assets

407.6k

+0.05%

cash

0

0%

net assets

Total assets minus all liabilities

a a polypharma limited company details

company number

08596634

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

July 2013

age

11

accounts

Micro-Entity Accounts

ultimate parent company

None

previous names

N/A

incorporated

UK

address

the gatehouse, 453 cranbrook road, ilford, essex, IG2 6EW

last accounts submitted

March 2023

a a polypharma limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 4 charges/mortgages relating to a a polypharma limited. Currently there are 0 open charges and 4 have been satisfied in the past.

charges

a a polypharma limited Companies House Filings - See Documents

datedescriptionview/download